Legis Daily

Synthetic Opioid Danger Awareness Act

USA117th CongressHR-2364| House 
| Updated: 12/9/2021
Andy Kim

Andy Kim

Democratic Representative

New Jersey

Cosponsors (2)
Chris Pappas (Democratic)Raul Ruiz (Democratic)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Synthetic Opioid Danger Awareness Act This bill requires the Department of Health and Human Services (HHS) to provide education and training related to synthetic opioids, including fentanyl and its analogues. Specifically, HHS must launch a public education campaign on the dangers of synthetic opioids and related issues. HHS must also produce training materials to prevent exposure to synthetic opioids for first responders and others who are at high risk of such exposure and disseminate the materials to ambulance transport personnel, local sheriff deputies, and other first responders and individuals in high-risk occupations.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-5633
Synthetic Opioid Danger Awareness Act
Apr 5, 2021
Introduced in House
Apr 5, 2021
Referred to the House Committee on Energy and Commerce.
Apr 13, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 131.
Nov 30, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-181.
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6693-6694; text: CR H6693)
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2364.
Nov 30, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 9, 2021
Considered as unfinished business. (consideration: CR H7541-7542)
Dec 9, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 14 (Roll no. 423).
View Vote
Dec 9, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 9, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    HR 116-5633
    Synthetic Opioid Danger Awareness Act


  • April 5, 2021
    Introduced in House


  • April 5, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 13, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • November 30, 2021
    Placed on the Union Calendar, Calendar No. 131.


  • November 30, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-181.


  • November 30, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • November 30, 2021
    Considered under suspension of the rules. (consideration: CR H6693-6694; text: CR H6693)


  • November 30, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2364.


  • November 30, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • December 9, 2021
    Considered as unfinished business. (consideration: CR H7541-7542)


  • December 9, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 14 (Roll no. 423).
    View Vote


  • December 9, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • December 9, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Congressional oversightDrug, alcohol, tobacco useEmergency planning and evacuationGovernment information and archivesGovernment studies and investigationsHealth information and medical recordsHealth personnelHealth promotion and preventive careLaw enforcement officersPrescription drugs

Synthetic Opioid Danger Awareness Act

USA117th CongressHR-2364| House 
| Updated: 12/9/2021
Synthetic Opioid Danger Awareness Act This bill requires the Department of Health and Human Services (HHS) to provide education and training related to synthetic opioids, including fentanyl and its analogues. Specifically, HHS must launch a public education campaign on the dangers of synthetic opioids and related issues. HHS must also produce training materials to prevent exposure to synthetic opioids for first responders and others who are at high risk of such exposure and disseminate the materials to ambulance transport personnel, local sheriff deputies, and other first responders and individuals in high-risk occupations.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-5633
Synthetic Opioid Danger Awareness Act
Apr 5, 2021
Introduced in House
Apr 5, 2021
Referred to the House Committee on Energy and Commerce.
Apr 13, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 131.
Nov 30, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-181.
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6693-6694; text: CR H6693)
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2364.
Nov 30, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 9, 2021
Considered as unfinished business. (consideration: CR H7541-7542)
Dec 9, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 14 (Roll no. 423).
View Vote
Dec 9, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 9, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    HR 116-5633
    Synthetic Opioid Danger Awareness Act


  • April 5, 2021
    Introduced in House


  • April 5, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 13, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • November 30, 2021
    Placed on the Union Calendar, Calendar No. 131.


  • November 30, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-181.


  • November 30, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • November 30, 2021
    Considered under suspension of the rules. (consideration: CR H6693-6694; text: CR H6693)


  • November 30, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2364.


  • November 30, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • December 9, 2021
    Considered as unfinished business. (consideration: CR H7541-7542)


  • December 9, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 14 (Roll no. 423).
    View Vote


  • December 9, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • December 9, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Andy Kim

Andy Kim

Democratic Representative

New Jersey

Cosponsors (2)
Chris Pappas (Democratic)Raul Ruiz (Democratic)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightDrug, alcohol, tobacco useEmergency planning and evacuationGovernment information and archivesGovernment studies and investigationsHealth information and medical recordsHealth personnelHealth promotion and preventive careLaw enforcement officersPrescription drugs